Merck & Invivyd in Today’s December 18, 2023 News

Merck & Invivyd in the NEWS
Our post today comprises a premarket drug rejection. An important new approval for Merck's (MRK) Keytruda product, and exciting promising trial results for the firm Invivyd, Inc. (This content is for paid subscribers.

Please click here to subscribe or here to log in.